U.S. Markets closed

Alkame Water and NASCAR Driver John Hunter Nemechek Renew Brand Ambassador Relationship for 2016

LAS VEGAS, NV--(Marketwired - Jan 26, 2016) - Alkame Holdings, Inc. ( OTC : ALKM ), a health and wellness technology holding company with a focus on patentable, innovative, and eco-friendly consumer products, is pleased to announce that John Hunter Nemechek, driver of the No. 8 NEMCO Motorsports Chevrolet Silverado in the NASCAR Camping World Truck Series (NCWTS) for NEMCO Motorsports, has renewed a personal services agreement with Alkame Holdings, Inc. As a Team Alkame ambassador, Nemechek has a continued commitment to Alkame Water, Inc.'s patented formula of premium oxygenated, alkaline and antioxidant bottled water products known as 'the ultimate health and wellness water.'

The Mooresville, N.C., native began his racing career at five-years old and, today, at 18-years old, Nemechek is among an elite group of NASCAR Camping World Truck Series competitors that continue to establish themselves in NASCAR. In addition to his successful NASCAR Camping World Truck Series campaign in 2015, Nemechek was named to the 2015-2016 NASCAR Next class, and was awarded the 2015 Most Popular Driver for the NASCAR Camping World Truck Series.

John Hunter Nemechek is the son of NASCAR veteran driver 'Front Row' Joe Nemechek.

"I'm so glad that we are continuing our partnership with Alkame Holdings, Inc. as a brand ambassador for Alkame Water," Nemechek said. "I truly enjoy having Alkame Water in-hand, keeping me hydrated both now and in the upcoming 2016 NASCAR season."

"John Hunter has grown up around racing and is now coming of age, becoming one of the hottest drivers in the NASCAR Camping World Truck Series," Robert Eakle, Alkame CEO, said. "We couldn't be happier watching him win at the Chicagoland Speedway in September, as well as be voted on by fans as the Most Popular Driver for the NASCAR Camping World Truck Series." Eakle added, "We are so happy and proud to have John Hunter as one of our ambassadors, and continuing on with Team Alkame by representing our growing brand in the NASCAR community around the world."

About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and wellness technology holding company, with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiaries market and distribute enhanced waters utilizing an exclusive patented formula and technology to create water with several unique properties, enabling an increase to available oxygen content, optimized pH levels, as well as the added benefits of electrolytes, and enhancement of antioxidant properties, equating into many potential health benefits, such as a reduced structure for permeability, improved metabolic efficiency, a boosted immune system, improved cardio respiratory function, and a decrease in lactic acid for faster muscle recovery. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications to utilize its Intellectual Property by placement into several emerging business sectors, such as the growing aqua-culture industry, consumer bottled water and RTD products, household pet products, horticulture and agriculture applications, as well as many other various water treatment solutions to both new and existing business platforms.

For more information, visit www.alkameholdingsinc.com.

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.